- PIK3CA mutation as an acquired resistance driver to EGFR-TKIs in non-small cell lung cancer: Clinical challenges and opportunities
Xiaohong Liu et al, 2024, Pharmacological Research CrossRef - Three-dimensional chromatin analysis reveals Sp1 as a mediator to program and reprogram HPV-host epigenetic architecture in cervical cancer
Canhui Cao et al, 2024, Cancer Letters CrossRef - The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy
Xin Xie et al, 2022, Translational Oncology CrossRef - The Role of Gut Microbiota in Tumor Immunotherapy
Miao Wu et al, 2021, Journal of Immunology Research CrossRef - Exosomes: Potential Disease Biomarkers and New Therapeutic Targets
Maria I. Mosquera-Heredia et al, 2021, Biomedicines CrossRef - PD-1/L1 inhibitor plus chemotherapy in the treatment of sarcomas
Zhichao Tian et al, 2022, Frontiers in Immunology CrossRef - Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases
Maysaa Abdulla et al, 2023, Biomolecules CrossRef - Hot and cold tumors: Immunological features and the therapeutic strategies
Lianjie Wang et al, 2023, MedComm CrossRef - TIGIT is Frequently Expressed in the Tumor Microenvironment of Select Lymphomas
Diane Libert et al, 2024, American Journal of Surgical Pathology CrossRef - Boosting Anti-tumour Immunity Using Adjuvant Apigenin
Chuli Xiao et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef - PD-1 and PD-L1 Expression Levels as a Potential Biomarker of Chronic Rhinosinusitis and Head and Neck Cancers
Katarzyna Malinowska et al, 2023, Journal of Clinical Medicine CrossRef - Engagement of CD300c by a novel monoclonal antibody induces the differentiation of monocytes to M1 macrophages
Su In Lee et al, 2024, Immunobiology CrossRef - Identify the Prognostic and Immune Profile of VSIR in the Tumor Microenvironment: A Pan-Cancer Analysis
Yuanyuan Liu et al, 2022, Frontiers in Cell and Developmental Biology CrossRef - The Long-Term and Short-Term Efficacy of Immunotherapy in Non-Small Cell Lung Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis
Xianjing Chu et al, 2022, Frontiers in Immunology CrossRef - VISTA, PDL-L1, and BRAF—A Review of New and Old Markers in the Prognosis of Melanoma
Andreea Cătălina Tinca et al, 2022, Medicina CrossRef